Author

Yutao Pang

Institution: Guangdong Medical College

Observed institutions: Guangdong Medical College, Affiliated Hospital of Guangdong Medical College Hospital

ORCID: 0009-0005-9157-6877

Observed ORCID: 0009-0005-9157-6877

OpenAlex ID: A5113314863

Pembrolizumab therapy in a patient with NSCLC and bullous pemphigoid: A case report

2024 · Ang Li, Fasheng Li, et al. · Oncology Letters · 2

Immune-related LncRNA signatures define tumor microenvironment subtypes and predict immunotherapy response in NSCLC

2026 · Ang Li, Yutao Pang, et al. · Discover Oncology · 1

Automated quantification of tumor-infiltrating lymphocytes by machine learning reveals prognostic and immunogenomic features in lung cancer

2026 · Ang Li, Yutao Pang, et al. · Scientific Reports · 1

P204. A Radiomics-based Machine Learning Model for Non-invasive Prediction of Differentiation Grade in Stage IA Invasive Non-Mucinous Lung Adenocarcinoma Using Preoperative CT Imaging

2026 · Fa Sheng Li, Yutao Pang, et al. · Journal of Thoracic and Cardiovascular Surgery

Single-cell atlas reveals a pro-metastatic RELB+ neutrophil-myeloid subset underlying lymph node metastasis in EGFR-wildtype LUAD

2026 · Fasheng Li, Xiao Yang, et al. · Frontiers in Cell and Developmental Biology

Solitary fibrous tumor of the chest wall with Doege–Potter syndrome: a case report

2026 · Hongfei Zhang, Xinyue Weng, et al. · Frontiers in Oncology

HOXC-AS1: A Key Biomarker for Prognosis and Immunotherapy in Lung Adenocarcinoma

2025 · Haiyin Ye, Xiao Yang, et al. · Current Computer - Aided Drug Design

Works count: 7

Citation count: 4

H-index: 1

I10-index: